Welcome to our dedicated page for Itron SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Itron Inc. filings document the reporting, governance and capital-structure records of an operating company serving utility and city infrastructure markets. Recent 8-K disclosures cover operating results, financial-condition updates, material agreements and the issuance of convertible senior notes, including purchase agreement and indenture terms tied to the company’s debt and equity structure.
Proxy and shareholder-vote filings describe director elections, advisory executive-compensation votes and annual meeting matters for holders of Itron common stock. Other material-event filings record cybersecurity response and operational-continuity disclosures, while exchange-registration information identifies ITRI common stock, no par value, as listed on the Nasdaq Global Select Market.
Itron, Inc. director Sheri Savage reported receiving a grant of common stock as part of her board compensation. On July 1, 2026, she acquired 621 shares of Common Stock at a stated price of $0.00 per share under a grant, award, or other acquisition. Following this transaction, she directly holds 2,387 common shares. A footnote explains that independent members of Itron’s board receive these common stock grants quarterly as part of their annual compensation for board service, indicating this is a routine, compensation-related equity award rather than an open-market trade.
Perez Santiago reported acquisition or exercise transactions in this Form 4 filing.
Itron director Santiago Perez received a grant of 621 shares of common stock as part of his quarterly board compensation. The stock was awarded at no cash cost to him and is described as the regular grant independent board members receive. Following this award, his direct holdings increased to 12,519 common shares.
ITRON, INC. director Sanjay Mirchandani reported an acquisition of common stock through a compensation grant. On July 1, 2026, he received 621 shares of common stock at $0.00 per share as part of the quarterly equity retainer for independent board members. Following this award, his direct holdings increased to 6,824 shares of Itron common stock. This is a compensation-related grant rather than an open‑market purchase or sale.
LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Timothy M. Leyden received a grant of 248 shares of common stock as part of regular quarterly compensation for independent board members. The shares were awarded at no cash cost. Following this grant, he directly holds 16,253 common shares.
The filing notes that Mr. Leyden deferred receipt of 93 of the granted shares under Itron's Executive Deferred Compensation Plan, so only the remaining portion is received immediately while the deferred shares will be credited according to that plan's terms.
Lande Jerome J. reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Jerome J. Lande received a grant of 621 shares of common stock as compensation for board service. The award is part of the quarterly stock grants that independent members of Itron's board receive toward their annual compensation. Following this grant, Lande directly holds 10,765 shares of common stock.
JAEHNERT FRANK M reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Frank M. Jaehnert reported receiving a grant of 621 shares of common stock as part of his quarterly board compensation. The shares were awarded at no cash purchase price and increased his directly held position to 23,118 common shares. According to the disclosure, he deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the award is part of his non-employee director compensation structure rather than an open-market transaction.
Drury Scott D. reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Scott D. Drury received a grant of 621 shares of common stock as part of his quarterly board compensation. The award was recorded at a price of $0.00 per share, reflecting that it is a compensation grant rather than a market purchase.
Following this grant, Drury directly holds 2,344 shares of Itron common stock. According to the disclosure, he deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the shares are credited for his benefit but delivery is postponed.
Itron, Inc. senior vice president John F. Marcolini sold 11,400 shares of Common Stock in an open-market transaction at $82.99 per share. After the sale, he directly holds 13,289 shares. The trade was executed under a pre-arranged Rule 10(b)5-1 Trading Plan adopted by Mr. Marcolini on February 23, 2026, indicating it was scheduled in advance rather than timed discretionarily.
John F. Marcolini reported Rule 144 sales of company common stock. The filing lists two sales: 05/20/2026 sale of 267 shares for $21,252.56 and 05/26/2026 sale of 322 shares for $27,166.08. The notice also lists multiple restricted stock vesting events on specific dates in 2025–2026 with individual share counts.
ITRON, INC. senior vice president of Outcomes Donald L. Reeves III sold 293 shares of common stock in an open-market transaction at $84.50 per share on May 27, 2026. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by Mr. Reeves on September 11, 2025, and he continued to hold 28,807 shares of common stock directly after the transaction.